Sigachi Industries Limited, a leading player in pharmaceutical excipients and active ingredients, has received the Terms of Reference (ToR) from the State Environment Impact Assessment Authority (SEIAA), Andhra Pradesh for its upcoming Bulk Drugs, Drug Intermediates, and Specialty Chemicals facility at Orvakal, Kurnool District.

This strategic project is proposed over 25.09 acres at Plot No. A-10, Guttapadu-Orvakal Node. The facility falls under Category B1, aligned with Schedule 5(f) of the EIA Notification, 2006, applicable to the Synthetic Organic Chemicals sector.

With the Terms of Reference now in place, the Environmental Clearance (EC) process is set to commence from 15th July 2025, followed by project development activities beginning from 1st August 2025.

The project will be instrumental in enhancing the company's API manufacturing capacity and global reach. It will also support pipeline expansion for regulated and semi-regulated markets.

Commenting on this development, Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited, said: "This is a significant milestone in our journey to become a vertically integrated pharmaceutical manufacturing company. The Orvakal project will anchor our next phase of growth in APIs and specialty chemicals, helping us create scalable, sustainable, and compliant operations for global markets.

At Sigachi, we are strategically positioning ourselves to cater to increasing global demand by building capacity closer to key markets and regulatory jurisdictions. The new facility will not only strengthen our product supply chain but also enable faster commercialization, seamless tech transfers, and enhanced responsiveness to evolving customer requirements."